Mirae Asset Global Investments
TNDM icon

Mirae Asset Global Investments’s Tandem Diabetes Care TNDM Stock Holding History

Mirae Asset Global Investments’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-36,060
Closed -$672K – 1698
2025
Q2 		$672K Hold
36,060
– – ﹤0.01% 900
2025
Q1 		$692K Sell
36,060
-265,554
-88% -$7.77M ﹤0.01% 878
2024
Q4 		$11.1M Buy
301,614
+240,966
+397% +$8.15M 0.05% 285
2024
Q3 		$2.57M Buy
60,648
+21,282
+54% +$902K 0.01% 549
2024
Q2 		$1.59M Sell
39,366
-100,119
-72% -$4.18M 0.01% 637
2024
Q1 		$5.42M Buy
139,485
+8,627
+7% +$231K 0.01% 868
2023
Q4 		$3.9M Sell
130,858
-23,457
-15% -$487K 0.01% 972
2023
Q3 		$3.21M Sell
154,315
-9,497
-6% -$261K 0.01% 995
2023
Q2 		$4.04M Buy
163,812
+15,444
+10% +$497K 0.01% 954
2023
Q1 		$6.01M Buy
148,368
+3,478
+2% +$144K 0.01% 816
2022
Q4 		$6.46M Buy
144,890
+39,045
+37% +$1.77M 0.02% 742
2022
Q3 		$5.1M Sell
105,845
-3,684
-3% -$202K 0.01% 793
2022
Q2 		$6.48M Sell
109,529
-4,224
-4% -$347K 0.02% 752
2022
Q1 		$13.2M Sell
113,753
-11,068
-9% -$1.29M 0.03% 588
2021
Q4 		$18.8M Sell
124,821
-178,990
-59% -$24.2M 0.04% 465
2021
Q3 		$36.3M Sell
303,811
-56,209
-16% -$6.19M 0.09% 257
2021
Q2 		$35.1M Buy
360,020
+69,817
+24% +$6.23M 0.1% 253
2021
Q1 		$25.6M Buy
290,203
+76,107
+36% +$7.07M 0.09% 290
2020
Q4 		$20.5M Buy
214,096
+69,400
+48% +$7.15M 0.08% 310
2020
Q3 		$16.4M Buy
144,696
+134,590
+1,332% +$14.1M 0.08% 284
2020
Q2 		$1M Buy
+10,106
New +$806K 0.01% 910

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
FGP
Freestone Grove Partners San Francisco, California $14.2B AUM 24.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mirae Asset Global Investments's TNDM Position: Q3 2025 in Review

Mirae Asset Global Investments sold out of Tandem Diabetes Care (TNDM) in Q3 2025, closing a stake of 36,060 shares — an estimated $672K sold.

Mirae Asset Global Investments first reported a position in TNDM in Q2 2020 and held it in 21 quarters. The position peaked at $36.3M in Q3 2021. 255 funds tracked by Wall St. Rank hold TNDM as of Q3 2025.

  • Mirae Asset Global Investments reported no remaining Tandem Diabetes Care position as of Q3 2025 after selling out during the quarter.
  • Mirae Asset Global Investments sold 36,060 Tandem Diabetes Care shares in Q3 2025, an estimated $672K.
  • Mirae Asset Global Investments first reported a position in Tandem Diabetes Care in Q2 2020 and held it in 21 quarters.
  • Mirae Asset Global Investments's Tandem Diabetes Care position peaked at $36.3M in Q3 2021.
  • 255 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2025.

Based on Mirae Asset Global Investments's 13F filing for Q3 2025, filed 3 Nov 2025.